Technique of ruthenium-106 application in the treatment of conjunctival melanoma.
In 1966 Lommatzsch has introduced the ruthenium-106 radiation therapy in the treatment of the choroidal melanoma. He reported on good results with a less rate of ocular side effects in compare to the different forms of conventional radiation therapy modalities. It seemed useful to utilize the advantages of ruthenium-106 therapy also for the treatment of the conjunctival melanoma. The technique of the ruthenium-106 irradiation of conjunctival melanoma is described and the first clinical results are reported.
Steinkogler
F J
FJ
II. University Eye Clinic, Vienna, Austria.
Binder
W
W
Seitz
W
W
D000368:Aged; D003131:Combined Modality Therapy; D003230:Conjunctival Neoplasms / Q000532:radiotherapy*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008545:Melanoma / Q000532:radiotherapy*; D008875:Middle Aged; D011879:Radiotherapy Dosage; D012429:Ruthenium Radioisotopes / Q000008:administration & dosage*; D013997:Time Factors
D012429:Ruthenium Radioisotopes